Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence

Background and objectives A flare-up in coronavirus disease 2019 (COVID-19) cases threatens the health of people, and though there is no proven pharmacological treatment, many analytical studies have suggested that interleukin-6 (IL-6) levels are elevated in cases of severe COVID-19 and that the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotak, Sohny, Khatri, Mahima, Malik, Mehreen, Malik, Maria, Hassan, Warda, Amjad, Arooba, Malik, Farheen, Hassan, Hani, Ahmed, Jawad, Zafar, Marium
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652362/
https://www.ncbi.nlm.nih.gov/pubmed/33178522
http://dx.doi.org/10.7759/cureus.10869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652362/
https://www.ncbi.nlm.nih.gov/pubmed/33178522
http://dx.doi.org/10.7759/cureus.10869

Ejemplares similares